Table 1.
Study | Chailurkit et al. [12] | Chailurkit et al. [13] | Kruavit et al. [14] | Soontrapa et al. [15] | Nimitphong et al. [16] | Charatcharoen-witthaya et al. [17] | Rojroongwasonkul et al. [18] |
---|---|---|---|---|---|---|---|
Year | 2011 | 2011 | 2012 | 2009 | 2013 | 2012 | 2013 |
Number of subjects | 2641 | 446 | 93 | 356 | 1990 | 120 | 3119 |
Mean age ± SD (year) | 40.3 ± 0.3a (range 15–98) |
67.5 ± 6.0 (range 60–97) |
75.2 ± 6.0 (range 61–97) |
35.2 ± 0.5a (range 20–50) |
40.1 ± 0.2a (range 25–54) |
29.3 ± 5.7 (range 18–40) |
N/A (range 3–12.9) |
Sex | M 50% F 50% |
F 100% | F 100% | F 100% | M 72.8% F 27.2% |
F 100% | N/A |
Mean 25(OH)D ± SD, ng/mL (nmol/L) | 31.8 ± 0.3a (79.3 ± 0.8a) |
27.1 ± 6.3 (67.6 ± 15.7) |
25.8 ± 6.0 (64.3 ± 14.9) |
29.1 ± 0.4 (72.6 ± 1.1) |
M 26.0 ± 0.2a (M 65.0 ± 0.5a) F 21.4 ± 0.2a (F 53.5 ± 0.5a) |
Trimester of pregnancy 1st 25.7 ± 6.7 (1st 61.4 ± 16.6) 2nd 33.8 ± 8.2 (2nd 84.4 ± 20.4) 3rd 36.1 ± 8.9 (3rd 90.0 ± 22.3) |
N/A |
Percent of subjects with 25(OH)D < 30 ng/mL (<75 nmol/L) | 45.2% | 54.0% | 77.4% | 77.8% | N/A | Trimester of pregnancy 1st 83.3% 2nd 30.9% 3rd 27.4% |
Age 3–5.9 yearsb
|
Percent of subjects with 25(OH)D < 20 ng/mL (<50 nmol/L) | 5.7% | 31.8% | 21.5% | N/A | M 13.9% F 43.1% |
Trimester of pregnancy 1st 26.7% 2nd 1.8% 3rd 2.3% |
M, male; F, female; N/A, not available.
Data was expressed as mean ± SEM.
Data was expressed as percent of subjects with 25(OH)D < 20 ng/mL (<50 nmol/L).